O18-5 Sacituzumab govitecan in Japanese patients with metastatic triple-negative breast cancer: phase 2 results of ASCENT J02
Title:
O18-5 Sacituzumab govitecan in Japanese patients with metastatic triple-negative breast cancer: phase 2 results of ASCENT J02
Author:
Naito, Y. Nakamura, S. Kawaguchi, N. Ishida, T. Nakayama, T. Yamamoto, Y. Masuda, N. Matsumoto, K. Kogawa, T. Sudo, K. Shimomura, A. Lai, C. Zhang, D. Iwahori, Y. Gary, D. Huynh, D. Iwata, H.